DNA opening during transcription initiation by RNA polymerase II in atomic detail.


Journal

Biophysical journal
ISSN: 1542-0086
Titre abrégé: Biophys J
Pays: United States
ID NLM: 0370626

Informations de publication

Date de publication:
15 11 2022
Historique:
received: 13 05 2022
revised: 01 09 2022
accepted: 07 10 2022
pubmed: 15 10 2022
medline: 22 11 2022
entrez: 14 10 2022
Statut: ppublish

Résumé

RNA polymerase II (RNAP II) synthesizes RNA by reading the DNA code. During transcription initiation, RNAP II opens the double-stranded DNA to expose the DNA template to the active site. The molecular interactions driving and controlling DNA opening are not well understood. We used all-atom steered molecular dynamics simulations to derive a continuous pathway of DNA opening in human RNAP II, involving a 55 Å DNA strand displacement and a nearly 360° DNA helix rotation. To drive such large-scale transitions, we used a combination of RMSD-based collective variables, a newly designed rotational coordinate, and a path collective variable. The simulations reveal extensive interactions of the DNA with three conserved protein loops near the active site, namely with the rudder, fork loop 1, and fork loop 2. According to the simulations, DNA-protein interactions support DNA opening by a twofold mechanism; they catalyze DNA opening by attacking Watson-Crick hydrogen bonds, and they stabilize the open DNA bubble by the formation of a wide set of DNA-protein salt bridges.

Identifiants

pubmed: 36230000
pii: S0006-3495(22)00832-3
doi: 10.1016/j.bpj.2022.10.012
pmc: PMC9703100
pii:
doi:

Substances chimiques

DNA 9007-49-2
DNA-Directed RNA Polymerases EC 2.7.7.6
RNA Polymerase II EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4299-4310

Informations de copyright

Copyright © 2022 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Mol Cell. 2020 Apr 16;78(2):275-288.e6
pubmed: 32160514
Nucleic Acids Res. 2008 Feb;36(2):676-87
pubmed: 18073196
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Structure. 2006 Oct;14(10):1527-34
pubmed: 17027501
Biophys Rev. 2016;8(Suppl 1):51-64
pubmed: 28035244
Nat Struct Mol Biol. 2013 Mar;20(3):396-403
pubmed: 23416947
Mol Cell. 2017 Feb 2;65(3):504-514.e4
pubmed: 28157507
Nat Struct Mol Biol. 2012 Aug;19(8):788-96
pubmed: 22751016
Front Mol Biosci. 2021 Nov 15;8:772486
pubmed: 34869598
Annu Rev Biophys. 2017 May 22;46:59-83
pubmed: 28532216
Nucleic Acids Res. 2021 Jan 8;49(D1):D480-D489
pubmed: 33237286
Science. 1996 Feb 16;271(5251):997-9
pubmed: 8584939
Nucleic Acids Res. 2011 May;39(9):3928-38
pubmed: 21247872
Science. 2001 Jun 8;292(5523):1876-82
pubmed: 11313499
Nature. 2021 Jun;594(7861):124-128
pubmed: 33902107
Nucleic Acids Res. 2009 Sep;37(16):5568-77
pubmed: 19586933
Nature. 2017 Nov 9;551(7679):204-209
pubmed: 29088706
J Comput Chem. 1999 Jun;20(8):786-798
pubmed: 35619462
EMBO J. 1997 Dec 15;16(24):7468-80
pubmed: 9405375
Nat Struct Mol Biol. 2008 Feb;15(2):146-54
pubmed: 18193062
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Mol Cell. 2005 Jul 1;19(1):101-10
pubmed: 15989968
J Am Chem Soc. 2012 Feb 1;134(4):2399-406
pubmed: 22206270
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15745-50
pubmed: 20798057
Nature. 2013 Mar 28;495(7442):481-6
pubmed: 23446344
Nature. 1970 Aug 8;227(5258):561-3
pubmed: 4913914
Cell. 2011 Dec 9;147(6):1257-69
pubmed: 22136875
J Chem Phys. 2007 Feb 7;126(5):054103
pubmed: 17302470
Nature. 2015 Feb 19;518(7539):376-80
pubmed: 25652824
Biophys J. 2013 Aug 6;105(3):767-75
pubmed: 23931324
Cell. 1993 May 7;73(3):533-40
pubmed: 8490964
Bioinformatics. 2014 Oct 15;30(20):2981-2
pubmed: 24996895
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):68-73
pubmed: 12506195
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):3961-6
pubmed: 25775526
J Chem Theory Comput. 2015 Dec 8;11(12):5723-36
pubmed: 26588601
Cell. 2021 Jul 22;184(15):4064-4072.e28
pubmed: 34133942
J Chem Inf Model. 2019 Sep 23;59(9):3803-3816
pubmed: 31385702
Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):12562-6
pubmed: 12271136
Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):
pubmed: 33883282
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13543-8
pubmed: 26483468
Phys Biol. 2014 Dec 05;12(1):016004
pubmed: 25475208
Nat Energy. 2019 Mar;2(3):228-235
pubmed: 31179024
Mol Cell. 2015 Jul 16;59(2):258-69
pubmed: 26186291
Nat Struct Mol Biol. 2013 Mar;20(3):387-95
pubmed: 23416946
Proc Natl Acad Sci U S A. 2014 May 27;111(21):7665-70
pubmed: 24753580
Annu Rev Cell Dev Biol. 2020 Oct 6;36:1-34
pubmed: 32822539
Science. 2000 May 26;288(5470):1418-22
pubmed: 10827951
PLoS Comput Biol. 2015 Jul 02;11(7):e1004354
pubmed: 26134169
Nat Struct Mol Biol. 2014 Jan;21(1):88-94
pubmed: 24317489
Nature. 2016 May 11;533(7603):359-65
pubmed: 27193682
Cell. 1994 Jan 28;76(2):357-69
pubmed: 8293469
Proc Natl Acad Sci U S A. 1987 Oct;84(20):7024-7
pubmed: 2823250
Science. 2001 Jun 8;292(5523):1863-76
pubmed: 11313498
Nat Methods. 2019 Aug;16(8):670-673
pubmed: 31363226
Nature. 2016 May 11;533(7603):353-8
pubmed: 27193681
Biophys J. 2010 Oct 20;99(8):2577-86
pubmed: 20959099
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417
Nat Commun. 2015 Oct 29;6:8851
pubmed: 26511109
Nature. 2009 Nov 19;462(7271):323-30
pubmed: 19820686
Nat Struct Mol Biol. 2019 Jun;26(6):397-406
pubmed: 31110295
Curr Opin Struct Biol. 2018 Apr;49:54-62
pubmed: 29414512
Mol Cell. 2019 Jan 3;73(1):97-106.e4
pubmed: 30472190

Auteurs

Jeremy Lapierre (J)

Theoretical Physics and Center for Biophysics, Saarland University, Saarbrücken, Germany.

Jochen S Hub (JS)

Theoretical Physics and Center for Biophysics, Saarland University, Saarbrücken, Germany. Electronic address: jochen.hub@uni-saarland.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH